Decrease in albendazole sulphonation during experimental fascioliasis in sheep.
1. The in vivo S-oxidation of albendazole was measured from the pharmacokinetic profile of albendazole sulphoxide and sulphone determined in young male sheep receiving oral albendazole (1.9 mg/kg). Studies were carried out before, and each month after, oral infestation by 150 metacercariae of Fasciola hepatica. 2. Parasitic pathology was ascertained by clinical observation of animals, and the increase in plasma antibodies directed against liver flukes. 3. Rate of conversion of sulphoxide to sulphone and rate of sulphone elimination, were respectively decreased by 47% and 87% at week 8 post-infection, whereas significant increases in the area under plasma sulphone concentrations versus time curve and mean residence time, occurred 4-12 weeks following the infestation. 4. A 58% decrease in albendazole sulphonation was demonstrated in liver microsomal preparations obtained from 8-week-infected sheep, while there was no change in the FAD-directed sulphoxidation of albendazole. 5. The transient impairment of albendazole sulphonation could be related to the decrease in liver microsomal cytochrome P450-dependent monooxygenases observed in sheep with a similar parasitic pathology.
Galtier
P
P
Laboratoire de Pharmacologie-Toxicologie INRA, Toulouse, France.
Alvinerie
M
M
Plusquellec
Y
Y
Tufenkji
A E
AE
Houin
G
G
D000284:Administration, Oral; D015766:Albendazole / Q000378:metabolism* / Q000493:pharmacokinetics; D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D005211:Fascioliasis / Q000378:metabolism*; D008297:Male; D010084:Oxidation-Reduction; D012756:Sheep; D013431:Sulfates / Q000378:metabolism; D013450:Sulfones / Q000378:metabolism; D013454:Sulfoxides / Q000378:metabolism
D013431:Sulfates; D013450:Sulfones; D013454:Sulfoxides; D015766:Albendazole